
07 Sep 2021
Cenkos: GENinCode Plc -- Genetic insights
GENinCode is a revenue generating clinical-genetic diagnostic company focused on the large and growing cardiovascular disease (CVD) market. Its products use bioinformatics and artificial intelligence to combine a patient's genetic and ‘classic' CVD risk factors (eg age, smoking and blood cholesterol) to provide a step change in the standard of care for CVD patients through more accurate and individualised CVD risk assessment allowing a more personalised treatment strategy for the patient. The co ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: GENinCode Plc -- Genetic insights
GENinCode PLC (GENI:LON) | 2.2 0 0.0% | Mkt Cap: 6.17m
- Published:
07 Sep 2021 -
Author:
Chris Donnellan -
Pages:
65 -
GENinCode is a revenue generating clinical-genetic diagnostic company focused on the large and growing cardiovascular disease (CVD) market. Its products use bioinformatics and artificial intelligence to combine a patient's genetic and ‘classic' CVD risk factors (eg age, smoking and blood cholesterol) to provide a step change in the standard of care for CVD patients through more accurate and individualised CVD risk assessment allowing a more personalised treatment strategy for the patient. The co ....